Trisilicate

CHEMBL2109882 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
216.3 g/mol
LogP
Phase
4

Magnesium trisilicate is an inorganic antacid compound that neutralizes gastric acid by reacting with hydrochloric acid to form magnesium chloride and silicon dioxide, providing symptomatic relief from acid-related disorders. It is used for gastroesophageal reflux disease, peptic ulcers, and dyspepsia, and also acts as an adsorbent that can bind bile acids in the stomach. Its prolonged buffering action and low sodium content make it suitable for long-term antacid therapy.

आणविक भार

216.2800 g/mol

TPSA

134.00 Ų

चिकित्सीय क्षेत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=[Si](O)O[Si](O)(O)O[Si](=O)O

InChI

InChI=1S/H4O8Si3/c1-9(2)7-11(5,6)8-10(3)4/h1,3,5-6H

Molecular Formula

H4O8Si3

HBD / HBA

4 / 8

घूर्णनीय बंधन

4

भारी परमाणु

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Magnesium trisilicate is an inorganic antacid compound that neutralizes gastric acid by reacting with hydrochloric acid to form magnesium chloride and silicon dioxide, providing symptomatic relief from acid-related disorders. It is used for gastroesophageal reflux disease, peptic ulcers, and dyspepsia, and also acts as an adsorbent that can bind bile acids in the stomach. Its prolonged buffering action and low sodium content make it suitable for long-term antacid therapy.

Yes, Trisilicate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2109882. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5311267. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.